Medication Assisted Treatment for Opioid Dependence (MATOD)
Webinar 27 Nov, 1:23 PM - 31 Dec, 2:00 PM (AEDT)
As dedicated healthcare professionals, we understand the critical need for comprehensive care in addressing opioid dependence. We would like to invite you to complete the Medication Assisted Treatment for Opioid Dependence (MATOD) program.
Why Join MATOD?
Tailored Learning: Access the program anytime, anywhere, at your own pace, through the user-friendly gplearning platform.
Expert Guidance: Navigate through eight meticulously curated modules designed to enhance your confidence and understanding in opioid management.
Practical Application: Gain invaluable insights into implementing opioid agonist therapy in your practice. Explore real-world case studies, clinical assessments, and medico-legal considerations specific to Victoria.
Module Highlights:
- Opioids and Concepts: Uncover the physiological and pharmacological foundations of opioids and explore their role in addiction therapy.
- Kinetics and Dynamics: Understand how the body processes methadone and buprenorphine and master their formulations and dynamics.
- Clinical Assessment: Equip yourself with the latest patient assessment methods tailored for the Alcohol and Other Drugs (AOD) treatment space.
- The Patient Arc: Navigate the clinical journey of opioid agonist therapy, from induction to cessation, and explore options for acute withdrawal and long-term care.
- Special Circumstances: Tackle challenging clinical scenarios, including intoxication, transfers, and pain management, with confidence.
- Pregnancy and Lactation: Address the unique challenges of opioid agonist therapy during pregnancy and lactation, ensuring the safety of both mother and child.
- Opioid Agonist Therapy in Victoria: Dive deep into the practical and medico-legal aspects of delivering opioid agonist therapy in our state.
- Nurse Practitioner Perspective (optional): Gain invaluable insights into addiction care from a nursing perspective, enriching your collaboration with nurse practitioners in the AOD space.
Take the Next Step:
Elevate your practice and make a profound impact in opioid dependence treatment.
For more information, visit
https://www.racgp.org.au/the-racgp/faculties/vic/matod
Non RACGP, register
HERE
Learning outcomes
- Identify opioid toxicity in a patient requesting a prescription for opioids.
- Recognise opioid withdrawal in a patient requesting a prescription for opioids.
- Decide when opioid use disorder is present in a patient requesting a prescription of opioids.
- Compare the formulations of methadone and buprenorphine.
- Compare the dynamics of methadone and buprenorphine.
- Compare the dynamics of sublingual buprenorphine and long-acting injectable buprenorphine.
- Detail the kinetics of methadone and buprenorphine to case management.
- With consideration to polypharmacy, identify important drug-drug interactions relevant to opioid agonist therapy.
- Explore an assessment plan for any patient presenting with a suspected opioid use disorder.
- Explain the difference in the assessments of patients with suspected prescription opioid use disorder versus heroin use disorder.
- Discuss the role of testing for patients with opioid use disorder.
Compare treatment options for both acute withdrawal management and long-term opioid therapy for patients presenting with opioid use disorder.
- Explain how to manage a patient arc on methadone.
- Explain how to manage a patient arc on sublingual buprenorphine.
- Explain how to manage a patient arc on long-acting injectable buprenorphine.
- Detail how vomiting, intoxication and overdose are managed for in the context of opioid agonist therapy.
- Describe how to manage the transfer of a patent between various types of opioid agonist therapy.
- Discuss how to manage a patient with hepatorenal impairment on opioid agonist therapy.
- Discuss how to manage acute pain in the context of opioid agonist therapy.
Discuss the principles of opioid agonist therapy in each stage of pregnancy peripartum and post-partum.
- Identify the risks of opioid withdrawal during pregnancy.
- Recognise how opioid agonist therapy dosing requirements may change in pregnancy.
- Recognise the safety profile of opioid agonist therapy during breast feeding.
- Explain what is required within a treatment plan for patients with opioid use disorder.
- Understand the Victorian medicolegal context to be able to manage patients with opioid use disorder.
- Provide appropriate overdose management advice.
- Identify where to seek help, support, and advice regarding the management of patients with opioid use disorder within the Victorian context.
- Understand the context for Nurse Practitioners in the opioid agonist therapy space.
- Understand the entry points for Nurse Practitioners into the opioid agonist therapy treatment space.
- Understand the clinical practice for Nurse Practitioners within the opioid agonist therapy treatment space.
Educational
Activities
8.0
hours
Measuring
Outcomes
0
hours
Reviewing
Performance
3.5
hours